Nanoparticles boost delivery of lung cancer drugs 30-fold

Lung cancer remains one of the world's deadliest cancers, yet despite decades of effort to develop new drugs, many fail because they don't stay in the body long enough to be effective or because they damage healthy organs. Now, Adelaide University researchers have developed a novel nanoparticle "delivery vehicle" that precisely targets cancer drugs to the lungs while helping to limit harmful side effects—a breakthrough that could reshape how the disease is treated.